Tong, X., Arasappan, A., Bennett, F., Chase, R., Feld, B., Guo, Z., . . . Njoroge, F. G. (2010). Preclinical Characterization of the Antiviral Activity of SCH 900518 (Narlaprevir), a Novel Mechanism-Based Inhibitor of Hepatitis C Virus NS3 Protease. American Society for Microbiology (ASM).
Chicago Style CitationTong, X., et al. Preclinical Characterization of the Antiviral Activity of SCH 900518 (Narlaprevir), a Novel Mechanism-Based Inhibitor of Hepatitis C Virus NS3 Protease. American Society for Microbiology (ASM), 2010.
MLA CitationTong, X., et al. Preclinical Characterization of the Antiviral Activity of SCH 900518 (Narlaprevir), a Novel Mechanism-Based Inhibitor of Hepatitis C Virus NS3 Protease. American Society for Microbiology (ASM), 2010.